| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PPIP5K1 |
| Uniprot No | Q6PFW1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-1433aa |
| 氨基酸序列 | MWSLTASEGESTTAHFFLGAGDEGLGTRGIGMRPEESDSELLEDEEDEVPPEPQIIVGICAMTKKSKSKPMTQILERLCRFDYLTVVILGEDVILNEPVENWPSCHCLISFHSKGFPLDKAVAYSKLRNPFLINDLAMQYYIQDRREVYRILQEEGIDLPRYAVLNRDPARPEECNLIEGEDQVEVNGAVFPKPFVEKPVSAEDHNVYIYYPSSAGGGSQRLFRKIGSRSSVYSPESSVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEIRYPVMLTAMEKLVARKVCVAFKQTVCGFDLLRANGHSFVCDVNGFSFVKNSMKYYDDCAKILGNTIMRELAPQFQIPWSIPTEAEDIPIVPTTSGTMMELRCVIAIIRHGDRTPKQKMKMEVKHPRFFALFEKHGGYKTGKLKLKRPEQLQEVLDITRLLLAELEKEPGGEIEEKTGKLEQLKSVLEMYGHFSGINRKVQLTYYPHGVKASNEGQDPQRETLAPSLLLVLKWGGELTPAGRVQAEELGRAFRCMYPGGQGDYAGFPGCGLLRLHSTFRHDLKIYASDEGRVQMTAAAFAKGLLALEGELTPILVQMVKSANMNGLLDSDGDSLSSCQHRVKARLHHILQQDAPFGPEDYDQLAPTRSTSLLNSMTIIQNPVKVCDQVFALIENLTHQIRERMQDPRSVDLQLYHSETLELMLQRWSKLERDFRQKSGRYDISKIPDIYDCVKYDVQHNGSLGLQGTAELLRLSKALADVVIPQEYGISREEKLEIAVGFCLPLLRKILLDLQRTHEDESVNKLHPLCYLRYSRGVLSPGRHVRTRLYFTSESHVHSLLSVFRYGGLLDETQDAQWQRALDYLSAISELNYMTQIVIMLYEDNTQDPLSEERFHVELHFSPGVKGVEEEGSAPAGCGFRPASSENEEMKTNQGSMENLCPGKASDEPDRALQTSPQPPEGPGLPRRSPLIRNRKAGSMEVLSETSSSRPGGYRLFSSSRPPTEMKQSGLGSQCTGLFSTTVLGGSSSAPNLQDYARSHGKKLPPASLKHRDELLFVPAVKRFSVSFAKHPTNGFEGCSMVPTIYPLETLHNALSLRQVSEFLSRVCQRHTDAQAQASAALFDSMHSSQASDNPFSPPRTLHSPPLQLQQRSEKPPWYSSGPSSTVSSAGPSSPTTVDGNSQFGFSDQPSLNSHVAEEHQGLGLLQETPGSGAQELSIEGEQELFEPNQSPQVPPMETSQPYEEVSQPCQEVPDISQPCQDISEALSQPCQKVPDISQQCQENHDNGNHTCQEVPHISQPCQKSSQLCQKVSEEVCQLCLENSEEVSQPCQGVSVEVGKLVHKFHVGVGSLVQETLVEVGSPAEEIPEEVIQPYQEFSVEVGRLAQETSAINLLSQGIPEIDKPSQEFPEEIDLQAQEVPEEIN |
| 预测分子量 | 159,5 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PPIP5K1重组蛋白的3篇参考文献及其摘要概括：
1. **"Structural and Functional Analysis of the Inositol Pyrophosphate Kinase PPIP5K1"**
- **作者**: Shears, S.B. 等
- **摘要**: 该研究解析了PPIP5K1的重组蛋白晶体结构，阐明其催化机制，发现其通过双磷酸化肌醇中间体调控细胞能量稳态，为开发相关代谢疾病疗法提供依据。
2. **"Recombinant PPIP5K1 Expression and Its Role in Cellular Phosphate Signaling"**
- **作者**: Wang, H. 等
- **摘要**: 通过大肠杆菌系统成功表达并纯化功能性重组PPIP5K1.实验证实其通过生成1.5-IP8调控细胞内磷酸盐动态平衡，影响细胞应激反应通路。
3. **"PPIP5K1 Recombinant Protein as a Therapeutic Target in Metabolic Disorders"**
- **作者**: Gokhale, N.A. 等
- **摘要**: 利用昆虫细胞表达系统制备高纯度PPIP5K1重组蛋白，揭示其在调节胰岛素信号通路中的作用，提示其作为糖尿病潜在治疗靶点的可能性。
若需更具体文献，建议通过PubMed或Sci-Hub检索关键词“PPIP5K1 recombinant protein”获取近年研究。
PPIP5K1 (Phosphatidylinositol Pentakisphosphate 1-Kinase 1), also known as IP6K1. is a member of the inositol phosphate kinase family that plays a critical role in regulating cellular inositol pyrophosphate metabolism. This enzyme catalyzes the phosphorylation of inositol hexakisphosphate (IP6) to synthesize 5-diphosphoinositol pentakisphosphate (5-IP7), a high-energy inositol pyrophosphate involved in diverse cellular processes, including energy homeostasis, vesicular trafficking, apoptosis, and DNA repair.
PPIP5K1 is ubiquitously expressed in mammalian tissues, with high levels observed in the brain, liver, and kidneys. Structurally, it contains a conserved kinase domain and a unique N-terminal domain implicated in protein-protein interactions. Dysregulation of PPIP5K1 has been linked to pathological conditions such as metabolic disorders, neurodegenerative diseases, and cancer. For instance, its role in modulating insulin signaling and mitochondrial function highlights its potential relevance in diabetes and obesity.
Recombinant PPIP5K1 protein is typically produced using heterologous expression systems (e.g., E. coli or mammalian cells) for biochemical and structural studies. Its recombinant form enables detailed analysis of enzymatic activity, substrate specificity, and interactions with binding partners. Recent studies also explore its therapeutic targeting, as inhibitors of PPIP5K1 show promise in preclinical models for metabolic syndrome and cancer. However, the precise molecular mechanisms underlying its cellular functions and disease associations remain under active investigation, emphasizing the need for further research to unravel its complex roles in health and disease.
×
